Parker Institute For Cancer Immunotherapy

Date of Award

12.10.18

Program

Type 1 Diabetes: Prevent and Delay T1D

Amount

$3,320,077

Term of Grant

36 months

Project Title

Understanding autoimmune diabetes following certain cancer immunotherapies.

Funds to support studies to understand the pathogenesis of autoimmunity and diabetes associated with cancer immunotherapy which may (1) help prevent and manage it, and (2) begin discovering triggers, mechanisms, and/or biomarkers that may be generalizable to common forms of type 1 diabetes.